Dual inhibition of CDK4 and FYN leads to selective cell death in KRAS-mutant colorectal cancer

Lignende værker

• Dual inhibition of VEGF and PARP suppresses KRAS-mutant colorectal cancer
  af: Zhong, Longhui, et al.
  Udgivet: (2020)
• Ribociclib (LEE011) suppresses cell proliferation and induces apoptosis of MDA-MB-231 by inhibiting CDK4/6-cyclin D-Rb-E2F pathway
  af: Tianqi Li, et al.
  Udgivet: (2019-12-01)
• Sensitivity of KRAS-Mutant Colorectal Cancers to Combination Therapy that Co-Targets MEK and CDK4/6
  af: Ziemke, Elizabeth K., et al.
  Udgivet: (2015)
• Integrated analysis of long noncoding RNA associated‐competing endogenous RNA as prognostic biomarkers in clear cell renal carcinoma
  af: Yin, Hang, et al.
  Udgivet: (2018)
• Efficacy of the combination of MEK and CDK4/6 inhibitors in vitro and in vivo in KRAS mutant colorectal cancer models
  af: Lee, Michael S., et al.
  Udgivet: (2016)